Injectable Magnetic Hydrogel Incorporated with Anti‐Inflammatory Peptide for Efficient Magnetothermal Treatment of Endometriosis
Open Access
- 7 October 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (44) , e2409778
Abstract
Endometriosis is a prevalent gynecological condition characterized by chronic pelvic pain, dysmenorrhea, and infertility, affecting ≈176 million women of reproductive age worldwide. Current treatments, including pharmacological and surgical interventions, are often associated with significant side effects and high recurrence rates. Consequently, there is an urgent need for innovative and safer therapeutic approaches. In this study, an injectable magnetic hydrogel nanosystem is developed designed for the dual‐purpose magnetothermal and anti‐inflammatory treatment of endometriosis. This hydrogel incorporates Fe3O4 nanoparticles alongside an anti‐inflammatory peptide. Upon magnetic activation, the Fe3O4 nanoparticles induce a localized hyperthermic response, raising the temperature of endometriotic lesions to 63.3 °C, effectively destroying endometriotic cells. Concurrently, the thermally responsive hydrogel facilitates the controlled release of the anti‐inflammatory peptide, thus modulating the inflammatory milieu. The biocompatibility and complete in vivo degradability of the hydrogel further enhance its therapeutic potential. The in vivo studies demonstrated that this injectable magnetic hydrogel system achieved a 90% reduction in the volume of endometriotic lesions and significantly decreased inflammatory markers, offering a promising non‐invasive treatment modality for endometriosis. By integrating precise lesion ablation with the modulation of the inflammatory microenvironment, this system represents a novel approach to the clinical management of endometriosis.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2023MH326)
- National Natural Science Foundation of China (81801476)
This publication has 51 references indexed in Scilit:
- Minimally Invasive Delivery of Percutaneous Ablation Agent via Magnetic Colloidal Hydrogel Injection for Treatment of Hepatocellular CarcinomaAdvanced Materials, 2024
- A Novel CRISPR/Cas9‐Encapsulated Biomimetic Manganese Sulfide Nanourchins for Targeted Magnetic Resonance Contrast Enhancement and Self‐Enhanced Chemodynamics‐Gene‐Immune Synergistic Tumor TherapyAdvanced Functional Materials, 2024
- Interventional Hydrogel Microsphere Controlled‐Releasing Curcumin for Photothermal Therapy against EndometriosisAdvanced Functional Materials, 2024
- Melanin‐Integrated Structural Color Hybrid Hydrogels for Wound HealingAdvanced Science, 2023
- An Injectable Hydrogel for Simultaneous Photothermal Therapy and Photodynamic Therapy with Ultrahigh Efficiency Based on Carbon Dots and Modified Cellulose NanocrystalsAdvanced Functional Materials, 2021
- An Organelle‐Specific Nanozyme for Diabetes Care in Genetically or Diet‐Induced ModelsAdvanced Materials, 2020
- Giant Magnetic Heat Induction of Magnesium‐Doped γ‐Fe2O3 Superparamagnetic Nanoparticles for Completely Killing TumorsAdvanced Materials, 2017
- Smart Ferrofluid with Quick Gel Transformation in Tumors for MRI‐Guided Local Magnetic ThermochemotherapyAdvanced Functional Materials, 2016
- Gadolinium‐Doped Iron Oxide Nanoprobe as Multifunctional Bioimaging Agent and Drug Delivery SystemAdvanced Functional Materials, 2015
- Monodisperse Magnetic Single‐Crystal Ferrite MicrospheresAngewandte Chemie International Edition, 2005